SCHEMBL3693799

SCHEMBL3693799

c1ccc(-c2cc(-c3ccc4c(ccc5ccccc54)c3)nc3c2ccc2c(-c4ccccc4)cc(-c4ccc5c(ccc6ccccc65)c4)nc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 2/20 0.45
CYP11B1 P15538 1/20 0.45
CYP1A1 P04798 1/20 0.45
ALDH1A1 P00352 5/20 0.45
MAPT P10636 3/20 0.45
HPGD P15428 3/20 0.45
KDM4E B2RXH2 2/20 0.45
MEN1 O00255 1/20 0.45
MPI P34949 1/20 0.45
KMT2A Q03164 1/20 0.45
ACACA Q13085 4/20 0.44
HSD17B10 Q99714 2/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
TOP1 P11387 1/20 0.41
HPRT1 P00492 1/20 0.41
CYP1A2 P05177 2/20 0.40
PIM1 P11309 1/20 0.40
ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13458896 0.98 CYP1B1 (0.44) CYP1B1CYP11B1CYP1A1ALDH1A1MAPT
SCHEMBL13458692 0.92 ACACA (0.43) CYP1B1CYP11B1CYP1A1ALDH1A1MAPT
SCHEMBL184973 0.90 CYP1A1 (0.56) CYP1B1CYP11B1CYP1A1ALDH1A1MAPT
SCHEMBL29373621 0.90 CYP1A1 (0.56) CYP1B1CYP11B1CYP1A1ALDH1A1MAPT
SCHEMBL29358046 0.90 CYP1A1 (0.56) CYP1B1CYP11B1CYP1A1ALDH1A1MAPT
SCHEMBL13458815 0.89 CYP1A1 (0.54) CYP1B1CYP11B1CYP1A1ALDH1A1MAPT
SCHEMBL439445 0.89 CYP1A1 (0.58) CYP1B1CYP11B1CYP1A1ALDH1A1MAPT
SCHEMBL13458682 0.87 CYP1A1 (0.49) CYP1B1CYP11B1CYP1A1ALDH1A1MAPT
SCHEMBL12648641 0.85 MAPT (0.50) CYP1B1CYP11B1CYP1A1ALDH1A1MAPT
SCHEMBL12112655 0.84 ACACA (0.51) ALDH1A1MAPTHPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778512-B2 Chemical compound for organic electronic device and organic electronic device NOVALED AG (DE) 2014-07-15 US disclosed
EP-2452946-B1 Pyridylphosphinoxides for organic electronic device and organic electronic device NOVALED AG (DE) 2014-05-07 EP disclosed
EP-2463927-B1 Material for organic electronic device and organic electronic device NOVALED AG (DE) 2013-08-21 EP disclosed
EP-2381502-B1 Organic semiconducting layer NOVALED AG (DE) 2013-08-14 EP disclosed
EP-2463927-A1 Material for organic electronic device and organic electronic device Novaled AG (DE) 2012-06-13 EP disclosed
US-20120119191-A1 Chemical Compound for Organic Electronic Device and Organic Electronic Device NOVALED AG (DE) 2012-05-17 US disclosed
EP-2452946-A1 Pyridylphosphinoxides for organic electronic device and organic electronic device Novaled AG (DE) 2012-05-16 EP disclosed
EP-2381502-A1 Organic semiconducting layer Novaled AG (DE) 2011-10-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120119191-A1 Chemical Compound for Organic Electronic Device and Organic Electronic Device SLCO4C1, OR10J3, EPCAM CYP1B1 65/4885CYP11B1 100/4885CYP1A1 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.